Penserra Capital Management LLC Purchases 7,130 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Penserra Capital Management LLC boosted its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 22.6% during the 3rd quarter, HoldingsChannel reports. The firm owned 38,716 shares of the real estate investment trust’s stock after purchasing an additional 7,130 shares during the period. Penserra Capital Management LLC’s holdings in Omega Healthcare Investors were worth $1,575,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in the company. Allworth Financial LP boosted its holdings in shares of Omega Healthcare Investors by 12.0% in the third quarter. Allworth Financial LP now owns 2,276 shares of the real estate investment trust’s stock worth $93,000 after buying an additional 244 shares during the last quarter. Venturi Wealth Management LLC boosted its stake in shares of Omega Healthcare Investors by 29.4% during the 3rd quarter. Venturi Wealth Management LLC now owns 1,259 shares of the real estate investment trust’s stock worth $51,000 after acquiring an additional 286 shares during the last quarter. Cutter & CO Brokerage Inc. grew its position in shares of Omega Healthcare Investors by 3.7% during the 2nd quarter. Cutter & CO Brokerage Inc. now owns 8,206 shares of the real estate investment trust’s stock valued at $281,000 after acquiring an additional 290 shares during the period. NCP Inc. increased its stake in shares of Omega Healthcare Investors by 10.3% in the 2nd quarter. NCP Inc. now owns 3,310 shares of the real estate investment trust’s stock worth $113,000 after purchasing an additional 310 shares in the last quarter. Finally, V Square Quantitative Management LLC raised its holdings in Omega Healthcare Investors by 49.5% in the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after purchasing an additional 323 shares during the period. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Trading Up 1.7 %

Shares of OHI stock opened at $40.77 on Wednesday. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. The stock has a market capitalization of $11.01 billion, a price-to-earnings ratio of 29.98, a price-to-earnings-growth ratio of 1.25 and a beta of 0.99. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $44.42. The stock’s 50-day moving average price is $40.61 and its 200-day moving average price is $37.19.

Omega Healthcare Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 6.57%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors’s payout ratio is 197.06%.

Insider Transactions at Omega Healthcare Investors

In other news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. The trade was a 36.19 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on OHI. Truist Financial boosted their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Wells Fargo & Company reissued an “overweight” rating and issued a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a report on Thursday, October 31st. BMO Capital Markets upped their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research report on Monday, October 7th. Finally, Royal Bank of Canada raised their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research report on Monday, November 11th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, Omega Healthcare Investors presently has an average rating of “Hold” and a consensus price target of $40.00.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.